Articles tagged "HIV virus"

2020 American Transplant Congress
An OPO’s Experience in Increasing Transplantation with the Hope Project
R. P. Wood, M. Ferguson, K. Myer, R. Cruz, P. Gillentine
CMO, LifeGift, Houston, TX
*Purpose: The purpose of this report is to describe one OPO’s experience in participating in the Hope Project. This research project is designed to evaluate…
2020 American Transplant Congress
Barriers for Kidney Transplant Evaluation among People Living with HIV and End-Stage Renal Disease in Mississippi
L. A. Shimose¹, M. X. Bueno Rios¹, J. Clark¹, A. Torres², D. Garcia-Anton², W. Cheungpasitporn², P. Vaitla², F. Cabeza-Rivera²
¹Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, ²Nephrology, University of Mississippi Medical Center, Jackson, MS
*Purpose: The number of Kidney transplants (KTx) among people living with HIV (PLWH) who develop end-stage renal disease (ESRD) has been increasing in many transplant…
2020 American Transplant Congress
The Forgiven Disease: Outcomes of Lung Transplantation in Two HIV-Infected Patients
S. Biswas Roy¹, M. T. Olson², M. A. Smith¹, R. M. Bremner¹, R. Walia¹, A. Arjuna¹
¹Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, ²University of Arizona College of Medicine - Phoenix, Phoenix, AZ
*Purpose: Human immunodeficiency virus (HIV) seropositivity is generally considered a contraindication to lung transplantation (LTx). HIV-infected adults are at higher risk of developing chronic lung…
2020 American Transplant Congress
Conversion to Belatacept in HIV(+) Renal Transplant Recipients
A. Santeusanio, A. Bhansali, R. Shapiro, G. De Boccardo
Mount Sinai Hospital, New York, NY
*Purpose: HIV(+) renal transplant recipients were excluded from phase III trials of belatacept, and currently there are only scattered case reports.*Methods: This was a single…
2020 American Transplant Congress
HIV+ Living Kidney Donors in the United States: Cases and a Clinical Paradigm
D. Segev¹, C. Wolfe², D. Brown³, D. Fine³, K. Neumann⁴, N. Martinez⁵, D. Ostrander³, F. Al Ammary³, A. Tobian³, A. W. Baker⁶, C. Durand³
¹Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, ²Duke University Medical Center, Durham, NC, ³Johns Hopkins University, School of Medicine, Baltimore, MD, ⁴Unaffiliated, N/A, VA, ⁵Unaffiliated, N/A, GA, ⁶Duke University, School of Medicine, Durham, NC
*Purpose: To report clinical characteristics and outcomes of two people living with HIV who underwent laparoscopic donor nephrectomy*Methods: To facilitate donor selection, we first conducted…
2020 American Transplant Congress
Willingness to Accept and Beliefs Regarding Organs from HIV-Infected Donors: A Multi-Center Survey of Transplant Candidates Living with HIV
S. Rasmussen¹, S. Seaman¹, M. Bowring¹, D. Brown¹, A. Massie¹, A. Tobian¹, M. Henderson¹, F. Fletcher², B. Smith², A. Chao³, N. Gorupati³, K. Prakash⁴, S. Aslam⁴, D. Lee⁵, S. Trinh⁶, V. Kirchner⁷, T. Pruett⁷, G. Haidar⁸, K. Hughes⁸, M. Malinis⁹, D. Segev¹, J. Sugarman¹, C. Durand¹
¹JHU, Baltimore, MD, ²UAB, Birmingham, AL, ³UCSF, San Francisco, CA, ⁴UCSD, San Diego, CA, ⁵Drexel, Philadelphia, PA, ⁶Ochsner, New Orleans, LA, ⁷UMN, Minneapolis, MN, ⁸UPMC, Pittsburgh, PA, ⁹Yale, New Haven, CT
*Purpose: HIV-infected (HIV+) donor to HIV+ recipient (HIV D+/R+) transplantation might improve access to transplantation for candidates living with HIV. However, it is unclear whether…
2019 American Transplant Congress
Optimal Timing of Hepatitis C Treatment among HIV/HCV Co-Infected End-Stage Renal Disease Patients: Pre vs. Post-Transplant
B. Shelton¹, G. Berdahl¹, D. Sawinski², B. Linas³, P. Reese², M. Mustian¹, R. Reed¹, P. MacLennan¹, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, ³Boston University School of Medicine, Boston, MA
*Purpose: End-stage renal disease (ESRD) patients co-infected with HCV and HIV have access to effective treatment options for HCV infection. However, they also have access…
2019 American Transplant Congress
HIV Resistance among HOPE Donor Referrals
B. Barnaba¹, W. Werbel¹, O. Kusemiju¹, C. Kirby¹, Y. Eby¹, R. Fernandez¹, J. Miller¹, A. Redd², D. Segev¹, A. Tobian¹, C. Durand¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²National Institute of Allergy and Infectious Diseases, Bethesda, MD
*Purpose: After success in South Africa, HIV+ deceased donor (HIV D+) organs can now be used for transplant to HIV+ recipients in the US under…
2019 American Transplant Congress
Patterns Of Anti-retroviral Use Among U.s. Liver Transplant Candidates With Hiv
A. A. Shaffer¹, A. G. Thomas², D. L. Segev³
¹Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC, ³Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD
*Purpose: There is a high burden of liver disease among HIV-infected (HIV+) individuals, and the class of antiretroviral therapy (ART) used for their treatment may…
2019 American Transplant Congress
HOPE Act Deceased Donors Referrals: Barriers to Donation
O. Kusemiju, C. Durand, B. Doby, M. Bowring, B. Barnaba, W. Werbel, D. Brown, A. Tobian, S. Seaman, D. Ostrander, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: HIV+ deceased donors (D+) represent a unique resource for HIV+ recipients but HIV D+ may have medical contraindications to donation or lower authorization rates.…